SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

15 Jul 2025 Evaluate

Dr Reddys Laboratories has informed that it enclosed a press release titled ‘Dr. Reddy's to release Q1FY26 results on Wednesday, July 23rd, 2025; Earnings call slated for Wednesday, July 23rd @ 19:30 PM IST / 10:00 AM ET’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1279.05 -0.65 (-0.05%)
12-May-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1855.10
Dr. Reddys Lab 1279.05
Cipla 1297.65
Zydus Lifesciences 937.30
Lupin 2274.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×